Donald J Hagler Jr
Overview
Explore the profile of Donald J Hagler Jr including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
110
Citations
5579
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mondragon-Estrada E, Newburger J, DePalma S, Brueckner M, Cleveland J, Chung W, et al.
iScience
. 2025 Jan;
28(2):111707.
PMID: 39877905
Neurodevelopmental impairments associated with congenital heart disease (CHD) may arise from perturbations in brain developmental pathways, including the formation of sulcal patterns. While genetic factors contribute to sulcal features, the...
2.
Makowski C, Shafiei G, Martinho M, Hagler Jr D, Pecheva D, Dale A, et al.
medRxiv
. 2024 Dec;
PMID: 39649610
Eating disorders (EDs) are multifaceted psychiatric disorders characterized by varying behaviors, traits, and cognitive profiles thought to drive symptom heterogeneity and severity. Non-invasive neuroimaging methods have been critical to elucidate...
3.
Loughnan R, Ahern J, Boyle M, Jernigan T, Hagler Jr D, Iversen J, et al.
Sci Adv
. 2024 Nov;
10(47):eadp4431.
PMID: 39576859
Our understanding of brain iron regulation and its disruption in disease is limited. Excess iron affects motor circuitry, contributing to Parkinson's disease (PD) risk. The molecular mechanisms regulating central iron...
4.
Tang R, Elman J, Reynolds C, Puckett O, Panizzon M, Lyons M, et al.
J Gerontol B Psychol Sci Soc Sci
. 2024 Oct;
79(12.
PMID: 39383177
Objectives: Childhood disadvantage is associated with lower general cognitive ability (GCA) and brain structural differences in midlife and older adulthood. However, the neuroanatomical mechanisms underlying childhood disadvantage effects on later-life...
5.
Bell T, Franz C, Thomas K, Williams M, Eyler L, Lerman I, et al.
J Gerontol A Biol Sci Med Sci
. 2024 Aug;
79(11).
PMID: 39169831
Background: Chronic pain leads to tau accumulation and hippocampal atrophy, which may be moderated through inflammation. In older men, we examined associations of chronic pain with Alzheimer's disease (AD)-related plasma...
6.
Lin S, Gillespie N, Notestine R, Gamst A, Chen A, McEvoy L, et al.
Am J Med Genet B Neuropsychiatr Genet
. 2024 Aug;
198(1):e33004.
PMID: 39148448
The prevalence of white matter disease increases with age and is associated with cerebrovascular disease, cognitive decline, and risk for dementia. MRI measures of abnormal signal in the white matter...
7.
Puckett O, Fennema-Notestine C, Hagler Jr D, Braskie M, Chen J, Finch C, et al.
Environ Health Perspect
. 2024 Jul;
132(7):77006.
PMID: 39028627
Background: Increased exposure to ambient air pollution, especially fine particulate matter () is associated with poorer brain health and increased risk for Alzheimer's disease (AD) and related dementias. The locus...
8.
Makowski C, Brown T, Zhao W, Hagler Jr D, Parekh P, Garavan H, et al.
Cereb Cortex
. 2024 Jun;
34(6.
PMID: 38880786
Neuroimaging is a popular method to map brain structural and functional patterns to complex human traits. Recently published observations cast doubt upon these prospects, particularly for prediction of cognitive traits...
9.
Tang R, Franz C, Hauger R, Dale A, Dorros S, Eyler L, et al.
Biol Psychiatry Cogn Neurosci Neuroimaging
. 2024 Jun;
9(10):975-985.
PMID: 38878863
Background: Early identification of Alzheimer's disease (AD) risk is critical for improving treatment success. Cortical thickness is a macrostructural measure used to assess neurodegeneration in AD. However, cortical microstructural changes...
10.
Tang R, Buchholz E, Dale A, Rissman R, Fennema-Notestine C, Gillespie N, et al.
Alzheimers Res Ther
. 2024 Apr;
16(1):90.
PMID: 38664843
Background: Plasma neurofilament light chain (NfL) is a promising biomarker of neurodegeneration with potential clinical utility in monitoring the progression of neurodegenerative diseases. However, the cross-sectional associations of plasma NfL...